News

International Women and Girls in Science Day 2026

Welcoming Robert Preece to the Consumer Advisory Panel. 

ANZSA at the 4th Annual Patient and Parliament Summit. 

During Sarcoma Awareness Month ANZSA collaborates with the VCCC Alliance to host two educational webinars. In this webinar learn about multidisciplinary insights and emerging therapies in liposarcoma care. 

During Sarcoma Awareness Month ANZSA collaborates with the VCCC Alliance to host two educational webinars. In this webinar learn about precision medicine in paediatric sarcoma. 

Introducing Dr Paul Daniel, one of the two ANZSA sarcoma research grant recipients of 2025. Paul has received funding from ANZSA to fund his project, evaluating:"Development of CD70 targeted antibody-drug conjugates for sarcomas"

Introducing Cui Tu (Maxine), one of the two ANZSA sarcoma research grant recipients of 2025. Maxine has received funding from ANZSA to fund her project, evaluating:

"First-in-field combinatorial therapy using anti-tumoral STING agonist to enhance chemotherapy effectiveness for hard-to-cure rhabdomyosarcomas."

The groundbreaking findings from an international collaborative clinical trial were unveiled today at the prestigious American Society of Clinical Oncology (ASCO) conference in Chicago.

In 2024, there will be a change in how ANZSA members receive our newsletters throughout the year.

Introducing the final ANZSA Sarcoma Research Grant Recipient for 2023, Professor Angela Hong. Prof. Hong has received funding for her project: Radiotherapy Quality Assurance for the Prospective study evaluating the treatment outcomes for localised recurrent, resectable retroperitoneal liposarcoma (ReLaPSe)

Introducing Dr. Minh-Son To, one of the four ANZSA sarcoma research grant recipients of 2023! Dr. To is receiving funding from  ANZSA and Rainbows for Kate Foundation for his project, Improving the radiological evaluation of bone and soft tissue sarcomas with advanced diffusion imaging and artificial intelligence.

Introducing Dr. Carolyn Shembrey, one of the four ANZSA sarcoma research grant recipients of 2023! Dr. Shembrey has received funding from ANZSA and the Kicking Goals For Xav Foundation to fund her project, Harnessing CRISPR-Cas13 to ablate ‘undruggable’ sarcoma drivers.